BioNexus Gene Lab Corp. (BGLC)

USD 2.69

(-3.5%)

Long Term Debt Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual long term debt in 2023 was 98.76 Thousand USD , up 145.64% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly long term debt in 2024 Q2 was 182.69 Thousand USD , down 0.0% from previous quarter.
  • BioNexus Gene Lab Corp. reported annual long term debt of 40.2 Thousand USD in 2022, up 7.39% from previous year.
  • BioNexus Gene Lab Corp. reported annual long term debt of 37.44 Thousand USD in 2021, down -51.8% from previous year.
  • BioNexus Gene Lab Corp. reported quarterly long term debt of 88.84 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • BioNexus Gene Lab Corp. reported quarterly long term debt of 29.65 Thousand USD for 2023 Q2, down -16.87% from previous quarter.

Annual Long Term Debt Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Long Term Debt of BioNexus Gene Lab Corp. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 98.76 Thousand USD 145.64%
2022 40.2 Thousand USD 7.39%
2021 37.44 Thousand USD -51.8%
2020 77.66 Thousand USD 35.55%
2019 57.29 Thousand USD -8.96%
2018 62.93 Thousand USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%

Peer Long Term Debt Comparison of BioNexus Gene Lab Corp.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD 96.787%
Biodesix, Inc. 35.22 Million USD 99.72%
bioAffinity Technologies, Inc. 1.11 Million USD 91.17%
Castle Biosciences, Inc. 14.19 Million USD 99.304%
DarioHealth Corp. 24.59 Million USD 99.598%
Exact Sciences Corporation 2.47 Billion USD 99.996%
IDEXX Laboratories, Inc. 622.88 Million USD 99.984%
Illumina, Inc. 1.48 Billion USD 99.993%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -21.444%
iSpecimen Inc. 29.13 Thousand USD -239.042%
Standard BioTools Inc. 3.98 Million USD 97.52%
23andMe Holding Co. 67.84 Million USD 99.854%
Medpace Holdings, Inc. 142.12 Million USD 99.931%
NeoGenomics, Inc. 606.06 Million USD 99.984%
Inotiv, Inc. 399.4 Million USD 99.975%
Psychemedics Corporation 945 Thousand USD 89.549%
Prenetics Global Limited 867.21 Thousand USD 88.611%
Precipio, Inc. 106 Thousand USD 6.827%
RadNet, Inc. 812.06 Million USD 99.988%
Sotera Health Company 2.22 Billion USD 99.996%
Star Equity Holdings, Inc. 1.14 Million USD 91.374%
Exagen Inc. 19.23 Million USD 99.486%
Natera, Inc. 282.94 Million USD 99.965%
Aspira Women's Health Inc. 1.43 Million USD 93.093%
Neogen Corporation 888.39 Million USD 99.989%
Myriad Genetics, Inc. 130.9 Million USD 99.925%
ICON Public Limited Company 3.66 Billion USD 99.997%
Bionano Genomics, Inc. 7.17 Million USD 98.624%
CareDx, Inc 28.27 Million USD 99.651%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 99.875%
Guardant Health, Inc. 1.13 Billion USD 99.991%
Fulgent Genetics, Inc. 10.11 Million USD 99.023%
Sera Prognostics, Inc. 840 Thousand USD 88.243%
OPKO Health, Inc. 222.03 Million USD 99.956%
Personalis, Inc. 1.23 Million USD 91.997%
Applied DNA Sciences, Inc. 739.16 Thousand USD 86.639%
Star Equity Holdings, Inc. 1.14 Million USD 91.374%
MDxHealth SA 35.56 Million USD 99.722%
Prenetics Global Limited 867.21 Thousand USD 88.611%
ENDRA Life Sciences Inc. 192.06 Thousand USD 48.578%
Mainz Biomed B.V. 2.19 Million USD 95.502%
Trinity Biotech plc 54.65 Million USD 99.819%
Neuronetics, Inc. 59.28 Million USD 99.833%
bioAffinity Technologies, Inc. 1.11 Million USD 91.17%